ABSTRACT
When presented with a patient manifesting the above symptoms, neurotologists often order both MR imaging and CT for further evaluation, MR imaging to exclude vestibular schwannoma and other tumors of the temporal bone, brain stem, and posterior fossa and to assess brain stem infarct, arterial dissection, and demyelinating disease; and CT to assess the integrity of the semicircular canals, rule out otosclerosis, and evaluate the middle ear for diseases such as cholesteatoma.
Patients and referring physicians are becoming more cognizant of the cost of performing 2 imaging studies, and many insurers are reluctant to reimburse for 2 imaging studies of the same body part. Additionally, there is added awareness of the risks of CT radiation. 9 Thin-section heavily T2-weighted imaging sequences such as FIESTA and constructive interference in steady state MR imaging are commonly used in imaging patients with vertigo, and their utility in evaluating cranial nerve pathology has been proved. 10, 11 The FIESTA sequence provides highcontrast definition between fluid and bone, and its high spatial resolution results in an exquisite anatomic definition of the membranous labyrinth. Motion artifacts are minimized by a balanced acquisition; hence, CSF pulsation artifacts are minimized. 12 We hypothesized that the absence of a hypointense layer between fluid in the semicircular canal and CSF on FIESTA should indicate an absence of bony coverage, or dehiscence. Conversely, the presence of a hypointense layer should indicate bone coverage and the absence of dehiscence. We undertook this study to determine whether FIESTA can replace CT of the temporal bone in evaluating patients for SC dehiscence.
MATERIALS AND METHODS

Design of the Study
We retrospectively reviewed 112 consecutive MR imaging and CT scans of the temporal bones obtained between October 2007 and October 2009 in 112 patients (39 men and 73 women, with 1 woman having been examined twice within a 14-month interval; mean age, 51 Ϯ 14 years; range, 17-85 years) referred for symptoms such as vertigo, dizziness, tinnitus, or hearing loss. The CT and MR imaging examinations were performed concurrently, at the request of the neurotology service.
The 112 examinations covering the bilateral temporal bones allowed the evaluation of 224 ears and the corresponding SSC and PSC of each ear. Because the lateral semicircular canal does not have an interface with CSF, it was not analyzed. MR imaging examinations were performed at 1.5T in 41 patients and at 3T in 71 patients. Scans were assigned a 10-digit reference number, and patient identifiers were removed for blinding. Analysis of the FIESTA sequence was performed first, for all patients and on both ears, with the MR imaging data being sorted by the date of acquisition. Analysis of CT images was then performed at least 2 weeks later, for all patients and on both ears. The data were sorted by the reference number, resulting in blinded comparison of FIESTA with CT.
Technical Considerations of MR Imaging and CT Acquisitions
All MR imaging scans included an axial high-resolution FIESTA acquisition covering both temporal bones; additional sequences dedicated to the brain were acquired but not analyzed for the purpose of this study. T2* gradient-echo localizers in 3 orthogonal planes were used to prescribe FIESTA acquisition through the Normal-appearing SSC (left ear) without dehiscence in a 17-year-old boy. FIESTA images show the SSC in a long-axis plane (A) and in a short-axis plane (B): the bright SC content corresponds to both perilymph and endolymph, and bone coverage has low signal intensity (arrows). Corresponding CT images of the same patient clearly demonstrate bone coverage (arrows) in the long-axis (C) and in the short-axis (D) planes. labyrinths. An 8-channel head coil was used on both 1.5T and 3T scanners (Signa HDX; GE Healthcare, Milwaukee, Wisconsin CT was performed on a helical 64-section scanner (LightSpeed VCT; GE Healthcare). All patients were examined in the supine position, and the gantry was not tilted. Images were acquired by using incremental axial scans, with a section thickness of 0.625 mm and no gap. Acquisition parameters were 190 mA and 140 kV. The images were reconstructed from the raw data with a 512 ϫ 512 matrix and a 10-cm FOV, leading to a 0.195 ϫ 0.195 mm pixel size in the plane of acquisition. A bone sharpening filter (Bone Plus, GE Healthcare) was used, with edge enhancement. The default-viewing parameters used were 4000 HU for window and 400 HU for level; these values could be adjusted if needed during the review process. Sagittal long-axis and 90°orthogonal shortaxis views in both SSC and PSC were performed as a standard by technologists for MR imaging and CT examinations, following the method described by Branstetter et al and Belden et al 13, 14 (example shown in Fig 1) , and were included in the dataset for analysis.
Data Analysis
SSC or PSC dehiscence assessment was done by consensus between 2 neuroradiologists (P.B., U.P.). This was achieved by reviewing the axial source images and reformations. If needed, additional multiplanar reformations were processed by the reviewing neuroradiologists from the axial source data on an Advantage Windows workstation (AWsuite 2.0.6.5.1z, Volume Viewer 2; GE Healthcare). For each patient, We analyzed both ears one after the other, with access to clinical data. Dehiscence was measured in millimeters on the long-axis view of the affected semicircular canal. The boundaries of the dehiscence were defined by highattenuation bone margins on CT and low-signal bone margins on FIESTA. The FIESTA sequence was used solely for MR imaging evaluation of the SC. Poor image data from artifacts, motion, and/or noninclusion of pertinent labyrinth anatomy precluded characterization of dehiscence in 20 semicircular canals (11 SSCs and 9 PSCs respectively). Of these 20 SCs, 4 SCs (in 3 patients; 3 SSCs and 1 PSC) had artifacts on both MR imaging and CT. The remaining 16 SCs (in 6 patients; 8 SSCs and 8 PSCs) were not characterizable on MR imaging, though they were clearly seen on CT.
Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for FIESTA results, by using the CT data as the standard reference.
Statistical Analysis
Statistical analysis was performed on PSPP (Release 0.6.0; SAS, Cary, North Carolina). We calculated confidence intervals for dehiscence assessment separately by using the conservative exact binomial-based method of Clopper-Pearson, considering results distribution. The standard Student t test was applied to compare measurements. The Fisher exact test was used to compare datasets distribution.
RESULTS
SSC Dehiscence
Of 224 possible SSCs, 213 were included in the analysis; 11 SSCs in 9 patients were excluded because of poor image quality due to motion or other artifacts on MR imaging and/or CT. Table 1 summarizes the SSC dehiscence detection by MR imaging and CT. Because there was no statistically significant difference (P ϭ .8) between the 1.5T and 3T datasets (Table 2) , we merged the two. The incidence of SSC dehiscence demonstrated on CT was 5.2% (11 cases of SSC dehiscence in 7 patients, 4 of whom had bilateral SSC dehiscence). The incidence of SSC dehiscence demonstrated on MR imaging was 8.5% (18 cases of SSC dehiscence in 12 patients, 6 of whom had bilateral SSC dehiscence).
MR imaging depicted all cases of SSC dehiscence seen on CT; therefore, the sensitivity was 100% (95% CI, 71.5%-100%). Specificity was 96.5% (95% CI, 93%-98.6%). An example of positive SSC dehiscence on MR imaging and CT can be seen in Fig 2. There were 7 falsepositive SSC dehiscence cases on MR imaging compared with CT (Fig 3) . The positive predictive value was 61.1% (95% CI, 35.7%-82.7%). Because there were no instances of SSC dehiscence missed on MR imaging, the negative predictive value was 100% (95% CI, 98.1%-100%).
PSC Dehiscence
Of 224 possible PSCs, 215 were included in the analysis; 9 PSCs in 7 patients were excluded for the same reasons described for SSC. Table 3 summarizes PSC dehiscence detection on MR imaging and CT. Because there was no statistically significant difference (P ϭ .29) between 1.5T and 3T datasets (Table 2) , we merged the two. The incidence of PSC dehiscence on CT was 0.5% (1 PSC dehiscence in 1 patient, Fig 4) . The incidence of PSC dehiscence on MR imaging was 1.4% (3 PSC dehiscence cases in 3 patients). MR imaging depicted the single PSC dehiscence seen on CT; therefore, the sensitivity was 100% (95% CI, 2.5%-100%). The specificity was 99.1% (95% CI, 96.7-99.9%). There were 2 false-positive PSC dehiscence cases on MR imaging compared with CT; therefore, the positive predictive value was 33.3% (95% CI, 0.8%-90.6%). Because there were no PSC dehiscence cases missed on MR imaging compared with CT, the negative predictive value was 100% (95% CI, 98.3%-100%).
Aggregate Data
Of the 448 SCs (SSC and PSC) in 112 patients, CT showed 12 cases of SC dehiscence (8 patients) in 444 canals analyzable; 4 Table 4 ). The remaining 22 patients (19.6%) had either at least 1 SC dehiscence seen on MR imaging or 1 SC excluded on MR imaging (13 patients with at least 1 SC dehiscence, 8 patients with at least 1 SC excluded, 1 patient with both a SC dehiscence and another SC excluded). Table 5 details the measurement of dehiscence in our cases positive for SC dehiscence, either with CT or MR imaging. For FIESTA dehiscence measurements, we separately analyzed cases in which a dehiscence was seen on CT and cases in which no dehiscence was seen on CT. The mean dehiscence measurement on CT (12 cases, 11 SSCs and 1 PSC) was 2.5 mm (95% CI, 1.8 -3.1 mm). For these true-positive cases, the corresponding mean dehiscence length on FIESTA was 3.8 mm (95% CI, 2.8 -4.8 mm). An example of a measurement is shown in Fig 5. The difference in dehiscence measurement between MR imaging and CT was significant (P ϭ .009, paired t test).
Dehiscence Measurement
The mean dehiscence value on MR imaging when there was no dehiscence seen on CT (9 cases, 7 SSCs and 2 PSCs) was 2.9 mm (95% CI, 2.0 -3.8 mm). Although this value is 23% lower (2.9 versus 3.8 mm), there was no significant statistical difference (P ϭ .18, t test unpaired) in the mean dehiscence as measured on FIESTA MR imaging between those cases with dehiscence demonstrated on CT and those cases with no dehiscence demonstrated on CT.
DISCUSSION
Fully refocused steady-state gradient-echo MR images such as FI-ESTA (other manufacturer-specific acronyms include "constructive interference in steady state," "b-FFE," and "True FISP" 12 )
offer a high signal-to-noise ratio that allows, within a reasonable time, submillimeter imaging and subsequent high-quality multiplanar reconstructions. FIESTA and similar sequences are typically included in MR imaging protocols to evaluate the internal auditory canal content for vestibular schwannoma because the high contrast between fluids and soft-tissue common to all steady Note:-SSCD indicates superior semicircular canal dehiscence; PSCD, posterior semicircular canal dehiscence. a Mean dehiscence length on FIESTA when present on CT was 3.9 mm. Mean dehiscence length on FIESTA when absent on CT was 2.9 mm. The difference between these 2 values is not statistically significant (P ϭ .18).
state free precession sequences, combined with high spatial resolution, can be advantageously used to evaluate the fluid-filled spaces of the inner ear. In this sequence, contrast is a function of the T2/T1 ratio in the target tissue, and tissues with long T2 values will usually have increased signal. 11 As a result, fluid in the membranous labyrinth has high signal, whereas cortical bone has null signal because of low proton density and very short T1 and T2. 15 These features result in very high contrast between the membranous labyrinth and the surrounding petrous bone. FIESTA is theoretically wellsuited for the evaluation of SC dehiscence by enabling discrimination of very thin bone coverage between the membranous labyrinth and CSF, which is essential in the diagnosis of SC dehiscence. 16 In our series, every SC dehiscence seen with CT was demonstrated on FIESTA, yielding a sensitivity of 100% in the FIESTA sequence compared with CT. FIESTA did, however, overestimate the presence of a dehiscence in 9 cases, with 21 cases of SC dehiscence seen on MR imaging and only 12 of them confirmed by CT. FIESTA depiction of bone coverage was less consistent than CT, leading to false-positive cases. In some instances, bony coverage of the semicircular canal is clearly so thin that signal loss is not perceivable on MR imaging, yet there was enough mineralization in it to be judged intact on CT. CT can demonstrate bone as thin as 0.1 mm, 14 but it also may overestimate SC dehiscence by as much as a factor of 10 compared with anatomic-pathologic correlation studies. 17 In evaluating the utility of FIESTA as a screening tool for SC dehiscence exclusion, the extreme sensitivity of this sequence for SC dehiscence despite a low positive predictive value appears to be an advantage. Our data show that a negative MR imaging finding effectively rules out SC dehiscence, with no case of dehiscence overlooked in our series. This result could have a significant impact on the imaging investigation of patients with vestibulocochlear signs and symptoms by reducing the need for temporal bone CT (by Ͼ80% of the patients in our series) in patients presenting with vestibulocochlear symptoms that could be due to SC dehiscence but with other retrocochlear pathologies in the differential diagnosis; this would decrease subsequent radiation exposure and also cost.
Conversely, CT is still mandatory to confirm dehiscence in cases in which it is suspected on FIESTA, due to false-positive cases and subsequent low positive predictive value.
We also measured the length of the observed dehiscences because neurotologists use this information to decide whether they will operate. It has been recently demonstrated that dehiscence of Ն2.5 mm on CT is associated with significantly more vestibulocochlear symptoms than smaller dehiscences, 18 perhaps because a relatively high number of small dehiscences seen on CT are probably not correlated with a real anatomic dehiscence. 17 When SC dehiscence was seen, the measure of the dehiscence obtained with FIESTA was, on average, Ͼ50% higher than the CT value, congruent with the assumption that FIESTA is less sensitive than CT in depicting very thin bone coverage; because of this difference, the 2.5-mm threshold used with CT cannot be transposed to FIESTA. When we compared the values of the dehiscence measurement on FIESTA between cases with and without dehiscence confirmed on CT, there was no significant difference, though we obtained a higher mean value of the dehiscence measured on FIESTA when there was a dehiscence seen on CT.
Limitations
The occurrence of SSC dehiscence and PSC dehiscence was 5.1% and 0.5% in our population, which is the expected incidence range in patients referred for vestibulocochlear symptoms 19 or anatomic-radiologic studies, 17 but lower than a more recent study by using equivalent CT technology. 20 This relatively low SSC and PSC dehiscence incidence leads to wide 95% confidence interval results for sensitivity and positive predictive value. Specificity and negative predictive value confidence intervals are much smaller but will also require confirmation with a larger population study. The incidence of SC dehiscence in the general asymptomatic population remains unknown. 21 This study did not evaluate lateral semicircular canal dehiscence, but that entity is more commonly associated with cholesteatoma. 22, 23 Some of the conditions that could result in a false-negative on FIESTA include banding artifacts, overlying blood vessels, and pneumocephalus. Banding artifacts due to field inhomogeneity are intrinsic to the FIESTA acquisition and produce curved hypointense lines. Banding artifacts were always well-recognized in 5T (A) shows the absence of a low-signal-intensity rim around the left SSC, suggesting dehiscence (arrowheads). At 3T (B), FIESTA again demonstrates clear absence of a low-signal-intensity rim around the SSC, suggesting dehiscence (arrowheads). The bone defect is measured at 4.4 mm on the 1.5T acquisition (A, black double-head arrow) and 4.2 mm on the 3T acquisition (B, black double-head arrow). Both 1.5T and 3T FIESTA acquisitions suggest SSC dehiscence. The small difference in measurement may be due to differences in magnetic susceptibility leading to greater conspicuity of bone coverage on the 3T FIESTA acquisition at both ends of the presumed dehiscence. In this case, CT (C) demonstrates a very thin but intact bone covering the SSC, excluding dehiscence (C, arrow).
our cases, rarely occurred exactly on the SC, and were not a problem for the analysis in any of our cases, but these are a potential pitfall. The constructive interference in steady state acquisition design includes 2 balanced steady state free precession runs with different flip angles to specifically address the banding artifacts problem but at a cost of a longer acquisition time. 12 Vascular structures lying just over a dehiscent SSC could potentially be mistaken for normal bone coverage, though the vessel should then be easily recognized on adjacent sections. Similarly, pneumocephalus that gives marked hypointense signal could theoretically mimic bone but would not be expected on MR images obtained in a healthy outpatient population. Temporal bone erosive processes such as cholesteatoma, glomus tumor, or metastasis can produce SC dehiscence by direct bone lysis, but these pathologies present as mass lesions that should be easily recognized on MR imaging and/or CT. Finally, another potential limitation is our use of both 1.5T and 3T MR imaging scanners. Although there was no apparent difference in data distribution and results, one could speculate that with a larger study population, very thin bony coverage might be more conspicuous on 3T FIESTA.
CONCLUSIONS
FIESTA reliably excludes SC dehiscence with a negative predictive value of 100% and therefore can be used as an effective screening tool in the evaluation of patients with vestibulocochlear symptoms. Due to a low positive predictive value for SC dehiscence, only patients who are thought to be positive for SC dehiscence should proceed to temporal bone CT in the absence of other indications for CT scanning, to determine whether true SC dehiscence exists. In our patient population, 80% of patients would have been spared undergoing CT, with consequent prevention of exposure to radiation and significant cost reduction in the work-up for SC dehiscence. 
